[go: up one dir, main page]

TR200909791A2 - Salmeterol ve flutikazon içeren farmasötik bileşim@ - Google Patents

Salmeterol ve flutikazon içeren farmasötik bileşim@

Info

Publication number
TR200909791A2
TR200909791A2 TR2009/09791A TR200909791A TR200909791A2 TR 200909791 A2 TR200909791 A2 TR 200909791A2 TR 2009/09791 A TR2009/09791 A TR 2009/09791A TR 200909791 A TR200909791 A TR 200909791A TR 200909791 A2 TR200909791 A2 TR 200909791A2
Authority
TR
Turkey
Prior art keywords
fluticasone
pharmaceutical composition
composition containing
salmeterol
containing salmeterol
Prior art date
Application number
TR2009/09791A
Other languages
English (en)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2009/09791A priority Critical patent/TR200909791A2/tr
Priority to US13/519,018 priority patent/US20130022650A1/en
Priority to PCT/TR2010/000250 priority patent/WO2011078823A1/en
Priority to EP10809108A priority patent/EP2515894A1/en
Publication of TR200909791A2 publication Critical patent/TR200909791A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, bir ? 2-agonisti olan salmeterol maddesi ve farmasötik olarak uygun tuzları ile bir kortikosteroit olan flutikazon maddesi ve farmasötik olarak uygun tuzlarının kombinasyonunu içeren bir farmasötik bileşimde, kromoglisik asit ve/veya nedokromil tuzlarının farmasötik etkinlik gösteren miktarlarda kullanımına ilişkindir.
TR2009/09791A 2009-12-25 2009-12-25 Salmeterol ve flutikazon içeren farmasötik bileşim@ TR200909791A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/09791A TR200909791A2 (tr) 2009-12-25 2009-12-25 Salmeterol ve flutikazon içeren farmasötik bileşim@
US13/519,018 US20130022650A1 (en) 2009-12-25 2010-12-20 Compositions containing salmeterol, fluticasone and cromoglicic acid
PCT/TR2010/000250 WO2011078823A1 (en) 2009-12-25 2010-12-20 Compositions containing salmeterol, fluticasone and cromoglicic acid
EP10809108A EP2515894A1 (en) 2009-12-25 2010-12-20 Compositions containing salmeterol, fluticasone and cromoglicic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/09791A TR200909791A2 (tr) 2009-12-25 2009-12-25 Salmeterol ve flutikazon içeren farmasötik bileşim@

Publications (1)

Publication Number Publication Date
TR200909791A2 true TR200909791A2 (tr) 2011-07-21

Family

ID=43799753

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/09791A TR200909791A2 (tr) 2009-12-25 2009-12-25 Salmeterol ve flutikazon içeren farmasötik bileşim@

Country Status (4)

Country Link
US (1) US20130022650A1 (tr)
EP (1) EP2515894A1 (tr)
TR (1) TR200909791A2 (tr)
WO (1) WO2011078823A1 (tr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
CA2338680C (en) * 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations
PE20020387A1 (es) * 2000-08-31 2002-06-24 Glaxo Group Ltd Uso de una combinacion de salmeterol y fluticasona
CA2555347A1 (en) * 2004-02-16 2005-09-01 Stephen Edward Augustyn Counter for use with a medicament dispenser
GB0714134D0 (en) * 2007-07-19 2007-08-29 Norton Healthcare Ltd Dry-powder medicament

Also Published As

Publication number Publication date
US20130022650A1 (en) 2013-01-24
WO2011078823A1 (en) 2011-06-30
EP2515894A1 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
CY1124928T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
UA109010C2 (en) Morpholino pyrividines and their use in therapy
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
BR112013023876A2 (pt) derivados de pirroltriazinona como inibidores de pi3k
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
GT201400016A (es) Indazoles
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
GT201200207A (es) Derivados de imidazopiridina como inhibidores de jak
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
UA112296C2 (uk) Сухий порошковий препарат, який містить інгібітор фосфодіестерази
BR112014007694A2 (pt) 1-pirazolil-3-(4-((2-anilinopirimidin-4-il)óxi)naftaleno-1-il)ureias como inibidores de p38 map cinase
BRPI1008227A8 (pt) composição de glicocorticoide inalável para uso na terapia de um paciente que sofre de asma severa e sem controle.
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
BR112014018953A8 (pt) Derivados de lupano triterpenoide e uso farmacêutico dos mesmos
PH12014500573A1 (en) Guanidinobenzoic acid compound
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia
TR201008226A2 (tr) Kapsül içeren bir inhalasyon cihazı.
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
BR112015027017A2 (pt) composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas
UY33723A (es) ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?.
TR200907917A2 (tr) Kuru toz inhaleri.
EA201171414A1 (ru) Ингибиторы белков семейства iap